|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/47 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| A61K 38/46 | (2006.01) |
| (11) | Number of the document | 1740204 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05715146.6 |
| Date of filing the European patent application | 2005-04-01 | |
| (97) | Date of publication of the European application | 2007-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-14 |
| (46) | Date of publication of the claims translation | 2018-06-25 |
| (86) | Number | PCT/DK2005/000228 |
| Date | 2005-04-01 |
| (87) | Number | WO 2005/094874 |
| Date | 2005-10-13 |
| (30) | Number | Date | Country code |
| 200400528 | 2004-04-01 | DK | |
| 558108 P | 2004-04-01 | US |
| (72) |
ANDERSSON, Claes, SE
FOGH, Jens, DK
WEIGELT, Cecilia, SE
ROCES, Diego, Prieto, DE
VON FIGURA, Kurt, DE
IRANI, Meher, US
|
| (73) |
Chiesi Farmaceutici S.p.A.,
Via Palermo 26/A, 43122 Parma,
IT
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Medicininis alfa-manozidazės panaudojimas |
| MEDICINAL USE OF ALPHA-MANNOSIDASE |
| Payment date | Validity (years) | Amount | |
| 2024-04-02 | 347.00 EUR |